SAME SESSION BI-DIRECTIONAL ENDOSCOPY – TIME FOR A TAILORED APPROACH

2019 ◽  
Author(s):  
M Alfa-Wali ◽  
CK Khoo ◽  
A Varma ◽  
M Saedon
Keyword(s):  
2013 ◽  
Vol 23 (3) ◽  
pp. 82-87 ◽  
Author(s):  
Eva van Leer

Mobile tools are increasingly available to help individuals monitor their progress toward health behavior goals. Commonly known commercial products for health and fitness self-monitoring include wearable devices such as the Fitbit© and Nike + Pedometer© that work independently or in conjunction with mobile platforms (e.g., smartphones, media players) as well as web-based interfaces. These tools track and graph exercise behavior, provide motivational messages, offer health-related information, and allow users to share their accomplishments via social media. Approximately 2 million software programs or “apps” have been designed for mobile platforms (Pure Oxygen Mobile, 2013), many of which are health-related. The development of mobile health devices and applications is advancing so quickly that the Food and Drug Administration issued a Guidance statement with the purpose of defining mobile medical applications and describing a tailored approach to their regulation.


2020 ◽  
Vol 71 (6) ◽  
Author(s):  
Lavinia Domenici ◽  
Maria G. Salerno ◽  
Pierluigi Benedetti Panici

2021 ◽  
Vol 16 (2) ◽  
pp. 183-186
Author(s):  
Roberto Ferrara ◽  
Corrado Campochiaro ◽  
Marina Chiara Garassino

2021 ◽  
Author(s):  
Marzieh Ahangarpour ◽  
Iman Kavianinia ◽  
Paul W. R. Harris ◽  
Margaret A. Brimble

Thiol–ene chemistry, a tailored approach to access novel peptide-based drugs.


Open Heart ◽  
2021 ◽  
Vol 8 (1) ◽  
pp. e001564
Author(s):  
Ole De Backer ◽  
Ivan Wong ◽  
Maurizio Taramasso ◽  
Francesco Maisano ◽  
Olaf Franzen ◽  
...  

The field of transcatheter mitral valve repair (TMVr) for mitral regurgitation (MR) is rapidly evolving. Besides the well-established transcatheter mitral edge-to-edge repair approach, there is also growing evidence for therapeutic strategies targeting the mitral annulus and mitral valve chordae. A patient-tailored approach, careful patient selection and an experienced interventional team is crucial in order to optimise procedural and clinical outcomes. With further data from ongoing clinical trials to be expected, consensus in the Heart Team is needed to address these complexities and determine the most appropriate TMVr therapy, either single or combined, for patients with severe MR.


Sign in / Sign up

Export Citation Format

Share Document